Xencor | XNCR - Pre Tax Profit


Xencor reported $-21.92M in Pre-Tax Profit for its fiscal quarter ending in June of 2026.





Pre Tax Profit Change Date
AbbVie USD 7.61B 2.04B Jun/2026
Alnylam Pharmaceuticals USD 177.81M 43.85M Jun/2026
Amgen USD 2.08B 570M Mar/2026
Arrowhead Research USD -178.9M 41.34M Jun/2026
AstraZeneca USD 4.81B 894M Jun/2026
Biogen USD 647.3M 269.6M Jun/2026
Bristol-Myers Squibb USD 4.99B 1.75B Jun/2026
Cytokinetics USD -206.03M 23M Mar/2026
GlaxoSmithKline GBP 2.68B 532M Jun/2026
J&J USD 7.67B 988M Sep/2026
Karyopharm Therapeutics USD -22.39M 17.51M Mar/2026
MacroGenics USD -36.77M 21.84M Mar/2026
Merck USD -3.53B 6.95B Mar/2026
Novartis USD 4.27B 430M Jun/2026
Pfizer USD -653M 5.84B Jun/2026
Regeneron Pharmaceuticals USD 1.53B 696.6M Jun/2026
Roche Holding CHF 11.17B 6.38B Jun/2026
Xencor USD -21.92M 106.72M Jun/2026